DreaMed Diabetes, an AI-based remote diabetes solution, is to be made available in clinics across the US, with a particular focus on rural communities.  The new tool, which is the first of its kind to be approved by the FDA, is cloud-based and uses AI to monitor glucose levels as well as lifestyle habits, providing clinicians with an analysis of this patients data.

Read more here.